Skip Navigation


Human Molecular Genetics Advance Access originally published online on August 5, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
12/suppl_2/R159    most recent
ddg259v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cheadle, J. P.
Right arrow Articles by Sampson, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheadle, J. P.
Right arrow Articles by Sampson, J. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, Review Issue 2 R159-R165
DOI: 10.1093/hmg/ddg259
© 2003 Oxford University Press

Exposing the MYtH about base excision repair and human inherited disease

Jeremy P. Cheadle* and Julian R. Sampson

Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK

Received June 19, 2003; Accepted July 29, 2003

Base excision repair (BER) protects against damage to DNA from reactive oxygen species, methylation, deamination, hydroxylation and other by-products of cellular metabolism. Until last year, inherited deficiencies in the BER pathway had not been causally linked with any human genetic disorder. An apparent explanation was functional redundancy between proteins in this and other pathways. However, it was recently discovered that biallelic mutations in the BER DNA glycosylase MYH lead to an autosomal recessive syndrome of adenomatous colorectal polyposis and very high colorectal cancer risk. We review the molecular mechanism of tumourigenesis in MYH polyposis, the preliminary delineation of the MYH polyposis phenotype and the functional overlap of MYH with other repair proteins.

* To whom correspondence should be addressed. Tel: +44 2920742652; Fax: +44 2920746551; Email: cheadlejp{at}cardiff.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
H. Gorgens, S. Kruger, E. Kuhlisch, C. Pagenstecher, R. Hohl, H. K. Schackert, and A. Muller
Microsatellite Stable Colorectal Cancers in Clinically Suspected Hereditary Nonpolyposis Colorectal Cancer Patients without Vertical Transmission of Disease Are Unlikely to Be Caused by Biallelic Germline Mutations in MYH
J. Mol. Diagn., May 1, 2006; 8(2): 178 - 182.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Frattini, I. Carnevali, S. Signoroni, D. Balestra, M. L. Moiraghi, P. Radice, L. Varesco, V. Gismondi, G. Ballardini, P. Sala, et al.
Cyclooxygenase-2 Expression in FAP Patients Carrying Germ Line MYH Mutations
Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 2049 - 2052.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Bai, S.ân Jones, X. Guan, T. M. Wilson, J. R. Sampson, J. P. Cheadle, and A-L. Lu
Functional characterization of two human MutY homolog (hMYH) missense mutations (R227W and V232F) that lie within the putative hMSH6 binding domain and are associated with hMYH polyposis
Nucleic Acids Res., January 26, 2005; 33(2): 597 - 604.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.